OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
May 31, 2026 — Cingulate advances CTx-1301 ADHD treatment with FDA acceptance and 2026 PDUFA date. Stonegate updates coverage as company prepares for potential commercial launch.
Ace Therapeutics Unveils Custom Stroke Models to Accelerate Hemorrhagic Stroke Research
January 24, 2026 — Ace Therapeutics offers customized hemorrhagic stroke models & CRO services to accelerate ICH research. Explore in vitro & in vivo models for preclinical development.
5 Key Reasons to Hire a Personal Injury Lawyer After an Accident
January 24, 2026 — Discover five compelling reasons to hire a personal injury lawyer after an accident, from serious injuries to insurance disputes. Learn how legal expertise can secure fair compensation and access free resources.
Soligenix Advances RiVax Vaccine Amid Rising Ricin Threat
January 23, 2026 — Soligenix develops RiVax vaccine against ricin toxin, supported by government grants. Recent ricin plot in India highlights urgent need for biodefense solutions.
LIXTE Biotech's Novel Cancer Strategy: Enhancing Existing Treatments
January 23, 2026 — LIXTE Biotechnology advances novel cancer treatment strategy with LB-100 compound targeting PP2A to enhance existing immunotherapy and chemotherapy effectiveness in clinical trials.
AHA Warns: Cold Weather Poses Serious Heart Attack, Stroke Risks
January 23, 2026 — The American Heart Association warns cold weather raises heart attack & stroke risk. Get crucial tips on staying safe while shoveling, dressing, and recognizing warning signs.
Weight Loss Reduces Psoriasis Severity, Improves Life Quality: Study
January 23, 2026 — New meta-analysis shows weight-loss interventions reduce psoriasis severity and improve quality of life. Research reveals crucial link between weight management and chronic skin condition treatment outcomes.
Shifa Therapy Expands Faith-Sensitive Mental Health Care for Muslims Worldwide
January 23, 2026 — Shifa Therapy expands faith-sensitive online mental health services for Muslims across US, Canada, UK with licensed therapists in New York, Toronto, London & more.
Oladoc Hits 1M+ Dermatologist Appointments, Fuels Pakistan's Aesthetic Boom
January 23, 2026 — Oladoc achieves 1 million+ dermatologist appointments in Pakistan, driving the aesthetic movement with accessible skincare and verified dermatologists for modern treatments.
Creative Biolabs Upgrades Biosimilar Development with Enhanced Characterization & CDMO Solutions
January 23, 2026 — Creative Biolabs upgrades biosimilar development services with enhanced characterization and one-stop CDMO solutions for monoclonal antibodies and other biologics.
UAE Online Therapy Platform Reports Equal Effectiveness, Greater Accessibility
January 23, 2026 — Counsel Clinic reports online therapy in UAE as effective as in-person sessions, offering affordable, culturally sensitive mental health support for depression, anxiety, and more.
Advocates Push HIPAA Reform to Save Lives in Mental-Health Crises
January 23, 2026 — Advocates urge HIPAA reform to improve family communication during mental-health crises, citing preventable tragedies and rising emergency visits. Learn how policy changes could save lives.
MNITF Launches 2026 PSA Campaign with Celebrities to Boost Organ Donor Awareness
January 23, 2026 — MNITF launches 2026 national PSA campaign with celebrities Eric Roberts, Wes Studi, and Michael Pare to promote kidney disease prevention and organ donor registration across TV, radio, and digital platforms.
HeartBeam Appoints Commercial Chief to Drive Cardiac Tech Expansion
January 22, 2026 — HeartBeam appoints Bryan Humbarger as chief commercial officer to lead launch of FDA-cleared 3D ECG system for arrhythmia assessment and heart attack detection.
Healthcare HR Summit Tackles 2026 Workforce Crisis: Burnout, AI & Staffing
January 22, 2026 — The 2026 People in Healthcare Summit addresses critical HR challenges like staffing shortages & burnout. Learn strategies for workforce resilience & AI integration in healthcare.
LIXTE's Novel Cancer Therapy Enhances Existing Treatments
January 22, 2026 — LIXTE Biotechnology advances LB-100, a novel PP2A inhibitor designed to enhance cancer immunotherapy and chemotherapy. Clinical-stage company pioneering first-in-class treatment approach.
Lexaria Hits 60 Global Patents, Urges Shareholder Vote for 2026 Meeting
January 22, 2026 — Lexaria Bioscience reaches 60 global patents, including new grants for hypertension and diabetes treatments. Shareholders urged to vote at the 2026 Annual Meeting for corporate governance.
HeartBeam Appoints New CCO to Drive Cardiac Tech Commercialization
January 22, 2026 — HeartBeam appoints Bryan Humbarger as CCO to lead commercial strategy for its FDA-cleared cardiac monitoring system, enhancing portable ECG technology for arrhythmia and heart attack detection.